My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
February 2018
FROM THE PRESIDENT
Severe Flu Season Highlights the Urgency of IDSA’s Top Priorities

I had the honor last week of sharing the podium with Massachusetts Senator Edward Markey as he introduced new legislation that would invest $1 billion in research toward a universal influenza vaccine. Like many of you, I am witnessing firsthand the devastating health consequences of this severe influenza season.

Read More

Paul Auwaerter, MD, MBA, FIDSA
IDSA President
TOP STORIES
IDSA & SHEA Release Updated Guidelines on C. diff

Updated guidelines on the diagnosis and treatment of Clostridium difficile (C. diff.) by IDSA and the Society for Healthcare Epidemiology of America (SHEA) have published in Clinical Infectious Diseases. Diagnosis and treatment of C. diff . has evolved significantly since the last guidelines were published in 2010.

Read More

CID Paper Makes Case for ID-Led Antimicrobial Stewardship

A paper published in Clinical Infectious Diseases describes how infectious diseases physicians are uniquely positioned to lead programs guiding the use of antimicrobial medicines.

Read More

An Improved IDSA Website is on the Horizon

As many of you know, IDSA and HIVMA have begun the process of redesigning our websites. This is long overdue, and we know that having a website that is easy to search and quickly provides what you’re looking for is important to your work.

Read More

Honor Your Colleagues: 2018 Society Awards Now Open

IDSA offers a full range of Society Awards to honor lifetime achievement, early career success, outstanding discoveries, inspirational mentors, innovative clinical teachers, and hard-working clinicians.

Read More

Journal Club
  • Shorter Antibiotic Courses for Enterobacteriaceae Bacteremia
  • Removing the Stigma of “Increased Risk” Organ Donors
  • Prolonged Infusion of Antipseudomonal β-Lactams and Lower Mortality in Patients With Sepsis
  • Updated Risk Factors for Herpes Zoster and Cost Effectiveness of the New Vaccine
  • How Willing Are ID Practitioners to Shorten the Duration of Antibiotic Therapy?

Read More

Upcoming dates to remember


The combined meeting of IDSA, SHEA, HIVMA, and PIDS, Oct. 3-7 in San Francisco, CA. See you there!

PATIENT CARE & SCIENCE
Sounding the Alarm on Infectious Diseases and the Opioid Epidemic
NIH “All of Us” Precision Medicine Initiative
CLINICAL PRACTICE MANAGEMENT
Using Telehealth to Provide Stewardship Training
POLICY & ADVOCACY
Federal Budget Proposal Severely Deficient in ID/HIV Funding
Comment Opportunity: HHS Establishes Division of "Conscience and Religious Freedom"
IDSA Weighs in on Public Health Preparedness and Response
Caring for Immigrant Patients with HIV & TB? New Resources Now Available
GLOBAL HEALTH
IDSA Presents at WHO Executive Board Session
Science Speaks Covers Resistance
EDUCATION & RESOURCES
IDWeek Call for Abstracts
ID Interest Group Funding Brings ID to Life for Med Students
FROM THE PRESIDENT
Severe Flu Season Highlights the Urgency of IDSA’s Top Priorities
TOP STORIES
IDSA & SHEA Release Updated Guidelines on C. diff
CID Paper Makes Case for ID-Led Antimicrobial Stewardship
An Improved IDSA Website is on the Horizon
Honor Your Colleagues: 2018 Society Awards Now Open
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.

Unsubscribe here